Status:
COMPLETED
Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging
Lead Sponsor:
Sytheon Ltd.
Conditions:
Photoaging
Eligibility:
FEMALE
35-65 years
Phase:
NA
Brief Summary
Photoaging is a common concern within the cosmeceutical industry with many products that are available. One frequently used product is hydroquinone that is used to even skin tone. However, hydroquinon...
Eligibility Criteria
Inclusion
- Females aged 35-65 (limiting to females so that there is not heterogeneity with the influence of hormones. Also, females are a much larger user base of skin care products)
- Individuals who have not participated in any other clinical studies using the same test sites (face) and hand in the past 14 days
- Individuals with Fitzpatrick skin type I-IV
- No known medical conditions that, in the investigator's opinion, may interfere with study participation.
Exclusion
- • Individuals who have been on any medication that has caused a change in skin pigmentation based on the opinion of the investigator
- Individuals who have history of acute or chronic disease that would likely interfere with or increase the risk on study participation at the discretion of the investigator
- Female volunteers who are pregnant or are actively breastfeeding or planning a pregnancy within two months. (There is no concern for risk to fetus but pregnancy can alter skin pigmentation)
- Female volunteers who have started a new hormonal birth control agent or switched to a hormonal birth control agent within the past 60 days
- Individuals who have had any medical or cosmetic procedure, such as laser resurfacing, or plastic surgery to the test site (face) within the last 6 months. This includes botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure
- Individuals who are currently using or during the past 30 days have used hydroquinone, or a retinoid such as Retin A, or other Rx/OTC Retinyl A.
- Individuals who have used salicyclic acid, beta hydroxy acid, vitamins A, C, E in the 14 days prior to first visit.
- Individuals with a known history of hypersensitivity to any ingredients to the cosmetic agent that is being assessed
- Individuals who are pregnant, breast feeding or planning a pregnancy.
- Individuals who have history of a psychological illness or condition that would interfere with their ability to understand and follow the requirements of the study at the discretion of the investigator
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04345094
Start Date
July 1 2019
End Date
February 15 2020
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Integrative skin Science and Research
Sacramento, California, United States, 95815